News and updates from the Department of Surgery at Mass General Brigham
The following faculty members were recently appointed or promoted at Harvard Medical School.
Nicholas Berlin, MD, MPH, appointed assistant professor of surgery.
Akinobu Itoh, MD, PhD, appointed associate professor of surgery.
Serguei Melnitchouk, MD, MPH, promoted to associate professor of surgery .
Eric Sheu, MD, PhD, promoted to associate professor of surgery.
Ravindra Uppaluri, MD, PhD
Chief, Head and Neck Surgical Oncology, Dana-Farber and Brigham and Women’s Cancer Center
Chief, Division of Otolaryngology-Head and Neck Surgery, Brigham and Women’s Hospital
Endowed Chair in Otolaryngology, Brigham and Women’s Hospital
Professor of Otolaryngology Head and Neck Surgery, Harvard Medical School
Dr. Uppaluri is a professor in otolaryngology-head and neck surgery at Harvard Medical School and head and neck surgeon at Brigham and Women’s Hospital. He is board certified by the American Board of Otolaryngology-Head and Neck Surgery. His clinical interests include minimally invasive head and neck surgery, including endoscopic approaches for skull base tumors and transoral laser removal of head and neck cancers, thyroid surgery and salivary gland/ parotid tumor management. To help manage these complex conditions, Dr. Uppaluri works in a close, multidisciplinary fashion with colleagues in neurosurgery, plastic surgery, medical and radiation oncology.
Dr. Uppaluri completed his medical school and obtained a doctorate in molecular genetics at the University of Minnesota. He subsequently trained in otolaryngology- head and neck surgery at Washington University and Barnes-Jewish Hospital in St. Louis. He remained as a faculty member there for 16 years prior to moving to Boston in 2016. Dr. Uppaluri is the chief of head and neck surgical oncology at Dana-Farber and Brigham and Women’s Cancer Center and chief of the Division of Otolaryngology-Head and Neck Surgery at Brigham and Women’s Hospital.
Dr. Uppaluri’s research interests focus on basic and translational approaches to improving outcomes for patients with head and neck cancers. He leads an NIH funded laboratory focused on immunotherapy. He also been the leader of clinical trials integrating novel therapeutics into the surgical management of head and neck cancers
We are pleased to report that this year’s residency match results are in. Here are the first-year residents who will be joining our surgical residencies this June.
